Tue, 7 July 2015
Whole Foods’ new expansion plans involve MUCH smaller stores, here’s why. |
Mon, 6 July 2015
An update on the Greek financial crisis, an unconventional lending strategy, and what to expect in quarterly earnings. |
Fri, 3 July 2015
Apple Music launched earlier this week, but in the crowded music streaming landscape, can the service stand out? |
Fri, 3 July 2015
For years consumers have been curious about how BP will fair after the Deepwater Horizon incident, and with today’s events you’ll be pleased to know: it has nothing to do with Greece. |
Wed, 1 July 2015
Celgene Hands $1 Billion To Juno Therapeutics and health insurance on the exchanges will climb 4.4% next year. Our Motley Fool's Michael Douglass and Todd Campbell discuss the details. |
Tue, 30 June 2015
These are tough times to be a giant food conglomerate. The Motley Fool dives into the details. |
Mon, 29 June 2015
Greece is in turmoil, and ripples are spreading around the world. What’s at the heart of the crisis, and what’s coming next? |
Sun, 28 June 2015
Most consumers understand the annoyance of pop-up ads attempting to share what little important screen space you’ve currently got in front of you. While some consumers are still unaware of the miracle that is ad blocking, corporations like Google who rely on ads for revenue, are freely offering these services as extensions on their browsers. One would think the revenue stream would be affected, yet Apple is launching its ad block option with iOS 9 in the fall. Will this leave profits flat for investors, or does Google have something up their sleeve to defeat the downfall?
|
Thu, 25 June 2015
Offshore drillers have been hit hard in the last 6 months, how patient should investors be in waiting for a turnaround? |
Wed, 24 June 2015
Phillip Frost's Opko Health shares are soaring, but Fool's Michael Douglass and Todd Campbell worry that valuation has become a bit stretched. Here's why. |
Tue, 23 June 2015
Just why is off-price retail so good at making money? We answer this and more on today's consumer goods edition of Industry Focus. |
Mon, 22 June 2015
The Exports/Imports Bank guarantees loans to foreign companies to buy U.S. exports – find out why opinion on it is divided. |
Fri, 19 June 2015
Motley Fool analysts Dylan Lewis and Vincent Shen take a look at this week’s big splash IPO, FitBit, and explain why it’s such an unusual tech public offering. |
Thu, 18 June 2015
As oil drilling has become much less lucrative than it was just a year ago, many smaller companies in the business are starting to fold up shop. Although had they read their oil history text books they would have been ready for this.
On this episode Tyler and Taylor take a look at why this was probably inevitable and what it could mean for investors long term. |
Wed, 17 June 2015
Rumors that major health insurers are reportedly courting one another could shake up the health insurance industry. Motley Fool's Michael Douglass and Todd Campbell consider what could be behind industry consolidation. |
Tue, 16 June 2015
Gap recently announced it will be closing 175 of its North American stores – Motley Fool analysts Dylan Lewis and Vincent Shen discuss the future outlook for the company, its competitors, and the apparel industry at large. |
Mon, 15 June 2015
With the banking industry trading at across-the-board low valuations, is it a good time to pick up shares? |
Sat, 13 June 2015
The CEO of Twitter just stepped down and that has big implications for shareholders. |
Thu, 11 June 2015
In case you missed it, the United States has surpassed Russia and Saudi Arabia as the top oil producer in the world. It seems that we simply can't stop growing our production. Is this a good or bad thing over the long-term? Only our analysts [think they] know for sure. Tune in for the whole story! |
Thu, 11 June 2015
The Supreme Court is set to announce its ruling in King v. Burwell, a case that could put health insurance subsidies at risk for millions of people. Our Motley Fools discuss the potential ruling and its impact. |
Tue, 9 June 2015
Consumer Goods: Superstar Athletes, Household Brands, and Rabid Fans — The Billion Dollar Business of Endorsements
Sports Promotions are big business and that can have big implications for some of the world’s biggest brands. |
Mon, 8 June 2015
On this episode we take a look at the history and purpose of the Federal Reserve. |
Fri, 5 June 2015
Apple’s developers conference is right around the corner and that means a lot of news will be coming out of one of the world’s biggest tech companies. |
Thu, 4 June 2015
The oil price crash has forced oil companies to find creative ways to raise cash. |
Wed, 3 June 2015
Biotech stocks eye-popping run has investors nervous of a bubble. Healthcare Fool's Michael Douglass and Todd Campbell weigh in with their take on biotech valuation. |
Tue, 2 June 2015
Video games are a massive, multi-billion dollar business, and mobile growth is pushing the industry to new heights. Is gaming right for your portfolio? |
Mon, 1 June 2015
This episode we discuss how big data could revolutionize the future of the financial sector. |
Fri, 29 May 2015
The Motley Fool’s Daniel Sparks discusses Google’s latest developers conference and the tech giant’s ecosystem focused initiatives. |
Thu, 28 May 2015
In this week's episode, Sean and Tyler explore three topics on the minds of energy investors: Can coal survive? Will oil companies actually do something about climate change? And why is cash so important to energy investments? |
Wed, 27 May 2015
Amgen has shelved its once-promising psoriasis drug. Motley Fool's Michael Douglass and Todd Campbell help investors understand the impact. |
Tue, 26 May 2015
The Motley Fool’s Sean O’Reily and Vincent Shen discuss the latest buyout news concerning Time Warner Cable. |
Fri, 22 May 2015
The Motley Fool’s Sean O’Reilly and Dylan Lewis discuss the latest moves being made by Google to conquer the world of mobile. |
Thu, 21 May 2015
The Motley Fool's Tyler Crowe, Taylor Muckerman, and Sean O'Reilly discuss a slew of energy sector downgrades by Wall Steet investment banks and why long term investors should just ignore them. |
Wed, 20 May 2015
Johnson & Johnson has inked a licensing deal with Achillion Pharmaceuticals that could threaten Gilead Sciences market share in hepatitis C someday. Motley Fool's Michael Douglass and Todd Campbell dig into the details of this deal to see if Gilead Sciences investors should worry. |
Tue, 19 May 2015
The Motley Fool’s Sean O’Reilly and Vincent Shen discuss the energy drink market and how the world’s major beverage players are positioning themselves to cash in on this emerging trend. |
Mon, 18 May 2015
Technology is revolutionizing the financials space as we know it, from lending to investment advising, and more! |
Sun, 17 May 2015
On today’s edition of Industry Focus, we’ll hear how Facebook is taking iOS to the next level by making news available instantly, without leaving the comfort of your social media page. |
Thu, 14 May 2015
This week we saw two big buys with Noble Energy buying Rosetta Resources and Williams Companies buying out its subsidiary. Is this a signal that the merger and acquisition wave might actually happen? Taylor Muckerman and Tyler Crowe break down these deals and give some insight as to why the merger wave is taking so long and how these deals could shape the future landscape. |
Wed, 13 May 2015
Motley Fool's Michael Douglass and Todd Campbell dig into MannKind Corp.'s first quarter earnings to see if MannKind is a bargain, or a bust. |
Tue, 12 May 2015
Motley Fool analysts Vincent Shen and Sean O’Reilly dive into the online travel industry and discuss recent events within the space. |
Mon, 11 May 2015
Dividend aristocrats, REITs, red flags, and more – a broad look at dividend investing on today's edition of Industry Focus. |
Fri, 8 May 2015
Motley Fool analysts Dylan Lewis and Sean O’Reilly discuss big changes coming to the food delivery industry, with big tech leading the way. |
Thu, 7 May 2015
Offshore LNG is officially a thing now! Offshore rigs are getting their groove back, and Big Oil companies should stay out of alternative energy for a reason. Our energy team explains all these things in this week's episode of Industry Focus. |
Wed, 6 May 2015
Alexion Pharmaceuticals is paying $8.4 billion to buy Synageva, a company without any sales, so Fool analyst Michael Douglass and contributor Todd Campbell are digging into this deal to see what it may mean to biotech investors. |
Tue, 5 May 2015
Motley Fool analysts Sean O’Reilly and Vincent Shen dive into the data behind the supposed “death of cable”, where things aren’t all what they seem. |
Mon, 4 May 2015
Matt Koppenheffer and David Hanson return to the studio to discuss their trip to Omaha. |
Fri, 1 May 2015
Motley Fool analysts Dylan Lewis and Sean O’Reilly break down the week in tech earnings, and explain just how Selerity got its hands on Twitter’s earnings and what went wrong for LinkedIn in the first quarter. |
Thu, 30 April 2015
Fool Analysts Tyler Crowe and Taylor Muckerman dig into Big Oil's recent earnings results and find some interesting tidbits about oil prices and why the integrated business model has been successful for so many years in the world of oil. |
Wed, 29 April 2015
Anthem has been a big beneficiary of health insurance reform, so Motley Fool analyst Michael Douglass and contributor Todd Campbell dig into Anthem's first quarter results to see if the ACA continues to drive results higher. |
Wed, 29 April 2015
Motley Fool analysts Sean O’Reilly and Dylan Lewis discuss Google’s new cell phone service, “Project Fi” as well as big news from Amazon. |
Tue, 28 April 2015
Motley Fool analysts Sean O'Reilly and Vincent Shen discuss why the Comcast / Time Warner Cable merger fell apart and where the industry goes from here. |
Mon, 27 April 2015
A 15-minute, 3-step guide to analyzing bank stocks. |
Thu, 23 April 2015
Oil services companies have been surprising Wall Street this week with better than expected results. Sean and Tyler take a look at why some companies in the space have been able do better than expected and identifies some of the important traits investors should look for when buying oil services stocks. |
Thu, 23 April 2015
A look at Rite Aid’s strategic initiatives for catching up to – and even passing – its competitors. |
Tue, 21 April 2015
Motley Fool Analysts Sean O’Reilly and Vincent Shen discuss the toy industry and how Foolish investors can invest in this huge business. |
Mon, 20 April 2015
Tune in to learn what this week’s earnings reports mean to owners of Wells Fargo, JPMorgan, and other big banks. |
Fri, 17 April 2015
Motley Fool Analysts Dylan Lewis and Sean O’Reilly discuss recent antritrust violations lobbed by the EU at Google Inc. |
Thu, 16 April 2015
Motley Fool Analysts Tyler Crowe and Sean O’Reilly discuss current myths surrounding the oil market: in particular battery tech advances. |
Wed, 15 April 2015
Two Motley Fool analysts dive into Johnson & Johnson's earnings and |
Tue, 14 April 2015
This Week in Consumer Goods: The Waltons Sell Shares in Wal-Mart and Netflix Prepares to Split Its Stock
Motley Fool analysts Sean O'Reilly and Dylan Lewis discuss the latest news in the world of consumer goods investing. |
Mon, 13 April 2015
Highlights from Jamie Dimon’s recent letter to shareholders, as well as a discussion of when is the right time to sell stocks. |
Mon, 13 April 2015
Motley Fool Analysts Sean O’Reilly and Dylan Lewis discuss recent venture capital investments in the technology industry and if they are getting too excessive. |
Fri, 10 April 2015
Taylor and Tyler look at the bullish and bearish viewpoints of Shell's recent decision to acquire BG Group for $70 billion. |
Wed, 8 April 2015
Expiring patents threaten billions of dollars in sales at Amgen. Here's what the company is doing to offset the threat to some of its best selling drugs. |
Tue, 7 April 2015
Motley Fool Analysts Sean O’Reilly and Vincent Shen discuss Google Fiber and its ramifications for the ISP industry |
Mon, 6 April 2015
The Oracle of Omaha is practically a force of nature in today’s investing world, but how will he be remembered a century from now? |
Thu, 2 April 2015
We’ve seen this before… High oil prices create a market where nearly everyone can make money. The surplus of production outstrips supply and prices subsequently fall. This leads to reduced capital investment. It’s called "cyclicality". Will 2020 be the next turning point due to underinvestment now? Find out on today's episode of Industry Focus. |
Wed, 1 April 2015
A drop dead, massively big, upside opportunity exists for this pre-clinical stage biotech star. Motley Fool analyst Michael Douglass and contributor Todd Campbell discuss this and much more. |
Wed, 1 April 2015
This week’s tech edition looks at Google’s new algorithm, Twitter’s Periscope, and the Facebook announcement that is all one of our analysts can talk about. |
Tue, 31 March 2015
Motley Fool Analysts Sean O’Reilly and Vincent Shen discuss the recent Kraft buyout in the context of past consumer goods mega-deals. |
Mon, 30 March 2015
This episode we learn why AmEx losing its Costco partnership is actually a long-term win. |
Thu, 26 March 2015
America's abundance of oil has some investors wondering how high levels of storage and shut in wells could impact energy stocks. So Taylor and Tyler break down the situation and give some quick words of caution. |
Wed, 25 March 2015
Can Amarin Corp Plc convert promise into profit? Motley Fool healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the challenges ahead for this volatile biotech stock. |
Tue, 24 March 2015
Motley Fool Analysts Sean O’Reilly and Vincent Shen discuss the merits and drawbacks of investing in the movie theatre industry. |
Tue, 24 March 2015
The competitive landscape of the financial industry has changed greatly over the last century – what does this mean for today’s banks? |
Fri, 20 March 2015
Nintendo stock is making moves, while Glu Mobile’s Kim Kardashian: Hollywood game is climbing the iTunes charts. Motley Fool analysts Nathan Hamilton and Sean O’Reilly discuss why on this week’s Industry Focus Podcast. |
Wed, 18 March 2015
A 742% spending surge for hepatitis C, pricey new diabetes medications, and one new drug class that has payers nervous -- all discussed today by healthcare analyst Michael Douglass and healthcare contributor Todd Campbell on today's Industry Focus. |
Tue, 17 March 2015
Motley Fool Analysts Sean O’Reilly and Vincent Shen Dive into the international businesses of some of America’s most storied household brands. |
Mon, 16 March 2015
Stress tests results reveal whether banks are prepared for economic downturn and if they can return more capital to shareholders. |
Fri, 13 March 2015
It was a busy week as normal for tech stocks. Microsoft made a bold move, Intel shares slumped, and Amazon is jumping into the booming IoT industry. Fool analysts Nathan Hamilton and Sean O'Reilly discuss each news event and what it means for shareholders. |
Fri, 13 March 2015
Today’s Industry Focus is talking Exxon, Chevron, and how not to fall prey to silly journalism in the energy space. |
Wed, 11 March 2015
MannKind and Orexigen: two companies with big promise, but can they deliver on profit? Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the risks facing these biotech stocks. |
Wed, 11 March 2015
Are shares of Chipotle copy-cats becoming overvalued? Tune in to find out. |
Mon, 9 March 2015
Initial bank stress tests results are out, and analysts discuss their importance and potential implications of this Wednesday’s round two results. |
Fri, 6 March 2015
The tech world was focused on one event this past week – The Mobile World Congress. Held in Spain, the event serves as barometer of tech trends in coming years. Fool analysts Nathan Hamilton and Sean O’Reilly sit down to discuss the event and what it means for investors. |
Wed, 4 March 2015
Healthcare analyst Michael Douglass and healthcare contributor Todd Campbell discuss the pitfalls and potential of two small cap biotech stocks. |
Tue, 3 March 2015
Motley Fool analysts Sean O’Reilly and Vincent Shen discuss the global gaming industry and opportunities for investors. |
Mon, 2 March 2015
Fool contributor John Maxfield takes on a few key points from this year’s letter to Berkshire Hathaway shareholders. |
Fri, 27 February 2015
A lot has been said about the concerns and potential capabilities of AI. But how close is AI is to becoming reality? It may be farther out on the horizon than some believe. |
Thu, 26 February 2015
With Seadrill and Transocean reporting earnings, some analysts out there are saying sell for some pretty ridiculous reasons. Here's why you shouldn't listen to them. |
Wed, 25 February 2015
In this healthcare edition of Industry Focus, healthcare analyst Michael Douglass and healthcare contributor Todd Campbell speculate which of these two biotech titans is a better buy. |
Tue, 24 February 2015
Join Motley Fool Analysts Sean O'Reilly and Vincent Shen for an investing happy hour as they discuss the alcohol industry. |
Mon, 23 February 2015
Falling oil prices and rising interest rates are two catalysts that could significantly impact the banking industry over the next year in far-reaching ways. |
Fri, 20 February 2015
Fool Tech analyst Nathan Hamilton recently returned from a trip to Asia and discusses some trends that Apple followers should pay attention to. |
Fri, 20 February 2015
SolarCity missed their EPS guidance and suffered a double-digit drop overnight. Meanwhile, analysts are jumping to conclusions about ExxonMobil’s glaring absence from Berkshire Hathaway’s holdings disclosure, but Taylor Muckerman has his own theory. |
Wed, 18 February 2015
In this episode of Industry Focus, analysts Michael Douglass and Todd Campbell discuss the oncoming opportunity with biosimilars and identify the stocks they’re most excited about in this space. |
Fri, 13 February 2015
Motley Fool Analysts Simon Erickson and Sean O’Reilly discuss two top plays for the emerging trend that is the Internet of Things |
Fri, 13 February 2015
Talking about the energy stocks we secretly admire as Valentines day approach |
Wed, 11 February 2015
In this week’s healthcare-focused episode of Industry Focus, analysts Michael Douglass and Todd Campbell discuss two small biotechs that recently reported hepatitis C data and look at their opportunity in this large and competitive market.
|
Mon, 9 February 2015
Find out why ideal balance sheets and superstar CEO’s are essential to the success of banks. |